Insilico Medicine Chairman To Buy Up To HK$16 Million Of Shares

Insilico Medicine (03696) said Chairman, Executive Director, Chief Executive Officer and Chief Commercial Officer Aleksandrs Zavoronkovs will use personal funds to buy shares in the open market, according to ETNet. The purchases are expected to take place during September, with the maximum total amount estimated at HK$16 million. The company said its issued shares are expected to continue to maintain sufficient public float after the buying.